Bausch Health Companies (BHC) Change in Accured Expenses (2009 - 2026)

Bausch Health Companies has disclosed Change in Accured Expenses across 18 years of filings, most recently posting $73.0 million for Q2 2026.

• In Q2 2026, Change in Accured Expenses fell 55.21% year-over-year to $73.0 million; the TTM figure through Jun 2026 stood at -$217.0 million (down 193.53% YoY), while the FY2025 annual figure was -$76.0 million, down 121.29% from the prior year.
• Change in Accured Expenses came in at $73.0 million for Q2 2026 at Bausch Health Companies, up from -$150.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $166.0 million in Q3 2023 to a low of -$284.0 million in Q4 2025.
• Average Change in Accured Expenses over 5 years is $15.9 million, with a median of $48.0 million recorded in 2022.
• Year-over-year, Change in Accured Expenses soared 737.5% in 2024 and plunged 1283.33% in 2025.
• Over 5 years, Change in Accured Expenses stood at $47.0 million in 2022, then surged by 106.38% to $97.0 million in 2023, then tumbled by 75.26% to $24.0 million in 2024, then sank by 1283.33% to -$284.0 million in 2025, then soared by 125.7% to $73.0 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $73.0 million in Q2 2026, -$150.0 million in Q1 2026, and -$284.0 million in Q4 2025.